Protein Expression Services Market Owing to Increasing Demand For Protein Biologics

According to Precision Business Insights (PBI) latest report the global protein expression services market was valued at USD 532.8 million in 2021, growing at a significant CAGR of 5.6% over 2022-2028. Globally, the ageing population, the rising prevalence of chronic diseases such as cancer, diabetes, and multiple sclerosis, and increased investment in protein-based research are likely to fuel market revenue growth throughout the forecast period. Emerging economies will almost certainly provide considerable growth prospects for market participants. Lack of qualified professionals, strict laws governing biologics production and commercialization, and expensive reagent and equipment prices are all projected to limit market expansion significantly throughout the projection period.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/global-protein-expression-services-market/

Cell-Free Protein Expression Segment Dominates the Protein Expression Services Market:
The market for protein expression services is projected to be dominated by cell-free expression. Cell-free protein expression has become well-established in the market due to its widespread acceptance, and this protein expression is carried out without the utilization of living cells. This technology has various advantages over other protein expression techniques, and as a result of these advantages, it is widely used. The cell expression market is growing due to the advantages of cell-free protein approaches, such as enhanced speed, capacity to produce hazardous proteins, and ease of amino acid type selective labelling, among others.

North America Leads Protein Expression Services Market:
Due to the presence of numerous large biopharmaceuticals, biotechnology, and pharmaceutical businesses in this region, including Merck KGaA, Pfizer Inc., F. Hoffmann-La Roche Ltd, and Amgen Inc., North America dominated the protein expression sector with the largest revenue share. The European market has grown due to a well-developed healthcare infrastructure and a strong focus on proteomics and genomics research activities in countries such as France, Switzerland, the United Kingdom, and Germany. Furthermore, due to the high prevalence of diabetes in this region, rising demand for biologics is likely to drive market expansion. The market in the Asia Pacific is predicted to grow at the fastest rate. The growing frequency of chronic diseases increased governmental and private investments, and increased life sciences research is the primary reasons driving this market's growth.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global protein expression services market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In June 2021, Thermo Fisher Scientific, the world leader in serving science, and Advanced Electrophoresis Solutions Ltd (AES), specialists in protein imaging technologies, has made an agreement to combine essential protein separation techniques with mass spectrometry (MS) to advance therapeutic protein development through streamlined characterization. In, Jan 2022, Merck KGaA, Darmstadt, Germany, a leading science and technology company, has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Exelead specializes in complex injectable formulations, including Lipid Nanoparticle (LNP) based drug delivery technology which is key in mRNA therapeutics for use in Covid-19 and many other indications.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=64007

The protein expression services market is segmented based on system, product, end-user industry, and geography.
Based on the System, the market is segmented into the following:
• Prokaryotic Expression Systems
• Mammalian Expression Systems
• Yeast Cell Expression Systems
• Insect Cell Expression Systems
• Cell-free Expression Systems
• Others

Based on the Product, the market is segmented into the following:
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• CROs
• Others

Based on the End-use Industry, the market is segmented into the following:
• Pharmaceutical and Biological Manufacturing
• Medical Devices Manufacturing
• Other Applications

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=64007

Key player's profiles in the protein expression services market report are Agilent Technologies, Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc, Merck KGaA, Promega Corporation, New England Biolabs, Qiagen, Takara Bio, Inc, Genscript Biotech Corporation, Oxford Expression Technologies Ltd, Synthetic Genomics Inc.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.